These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 36892308)
21. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation. Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536 [TBL] [Abstract][Full Text] [Related]
23. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318 [TBL] [Abstract][Full Text] [Related]
24. The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia. Law JP; Wood AJ; Friman VP Microbiol Spectr; 2022 Dec; 10(6):e0184222. PubMed ID: 36453898 [TBL] [Abstract][Full Text] [Related]
25. Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens. Zemanick ET; Wagner BD; Sagel SD; Stevens MJ; Accurso FJ; Harris JK PLoS One; 2010 Nov; 5(11):e15101. PubMed ID: 21152087 [TBL] [Abstract][Full Text] [Related]
26. Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis. Cigana C; Giannella R; Colavolpe A; Alcalá-Franco B; Mancini G; Colombi F; Bigogno C; Bastrup U; Bertoni G; Bragonzi A Microbiol Spectr; 2023 Feb; 11(1):e0408322. PubMed ID: 36625583 [TBL] [Abstract][Full Text] [Related]
27. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections. Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493 [TBL] [Abstract][Full Text] [Related]
29. The airway microbiome in cystic fibrosis and implications for treatment. Zemanick ET; Sagel SD; Harris JK Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150 [TBL] [Abstract][Full Text] [Related]
30. The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi. de Almeida OGG; Capizzani CPDC; Tonani L; Grizante Barião PH; da Cunha AF; De Martinis ECP; Torres LAGMM; von Zeska Kress MR Front Cell Infect Microbiol; 2020; 10():598938. PubMed ID: 33262957 [TBL] [Abstract][Full Text] [Related]
31. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients. Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432 [TBL] [Abstract][Full Text] [Related]
32. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum. Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256 [TBL] [Abstract][Full Text] [Related]
33. Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis. Saiman L; Waters V; LiPuma JJ; Hoffman LR; Alby K; Zhang SX; Yau YC; Downey DG; Sermet-Gaudelus I; Bouchara J-P; Kidd TJ; Bell SC; Brown AW Clin Microbiol Rev; 2024 Sep; 37(3):e0021521. PubMed ID: 39158301 [TBL] [Abstract][Full Text] [Related]
34. An Innovative Protocol for Metaproteomic Analyses of Microbial Pathogens in Cystic Fibrosis Sputum. Graf AC; Striesow J; Pané-Farré J; Sura T; Wurster M; Lalk M; Pieper DH; Becher D; Kahl BC; Riedel K Front Cell Infect Microbiol; 2021; 11():724569. PubMed ID: 34513734 [TBL] [Abstract][Full Text] [Related]
35. The cystic fibrosis lung microbiome. Surette MG Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409 [TBL] [Abstract][Full Text] [Related]
36. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400 [TBL] [Abstract][Full Text] [Related]
38. Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis. Boutin S; Graeber SY; Weitnauer M; Panitz J; Stahl M; Clausznitzer D; Kaderali L; Einarsson G; Tunney MM; Elborn JS; Mall MA; Dalpke AH PLoS One; 2015; 10(1):e0116029. PubMed ID: 25629612 [TBL] [Abstract][Full Text] [Related]
39. Cytokine patterns in cystic fibrosis patients with different microbial infections in oropharyngeal samples. Ghorban Movahed M; Abdi Ali A; Ghazanfari T; Modaresi M Cytokine; 2022 Dec; 160():156038. PubMed ID: 36150317 [TBL] [Abstract][Full Text] [Related]
40. Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung. Quinn RA; Lim YW; Maughan H; Conrad D; Rohwer F; Whiteson KL mBio; 2014 Mar; 5(2):e00956-13. PubMed ID: 24643867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]